LigoCyte Pharmaceuticals Adds More Funding
Bozeman, Montana-based LigoCyte Pharamceuticals has raised additional funding in the firm's most recently round, according to a regulatory filing from the firm Friday. According to the filing, the firm has now raised $29.49M in its latest funding, up from $28.0M announced by the firm in March of 2008. Source of the additional $1.49M in funding was not disclosed. LigoCyte is developing vaccines for norovirus and influenza infections. The firm has previously raised funding from Forward Ventures, JAFCO, Novartis Venture Fund, Fidelity Biosciences and MedImmune Ventures, Athenian Venture Partners and MC Life Sciences
Ventures.
posted on Monday, August 17, 2009 (Link to more information)
Related companies:
LigoCyte Pharmaceuticals
Related stories:
> LigoCyte Pharmaceuticals Raises $28M
> Ligocyte Acquired By Japanese Firm
> LigoCyte Pharmaceuticals Raises $6.5M
> Prolexys Pharmaceuticals Raises $20M
> Tolero Pharmaceuticals Bumps Series B To $22.4M
Techrockies.com Home